Get the Stockscreener App
278.25
0.12%
0.16
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $278.25, with a volume of 200.95K.
It is up +0.12% in the last 24 hours and up +9.82% over the past month.
See More
Previous Close:
$278.09
Open:
$279.02
24h Volume:
200.95K
Relative Volume:
0.14
Market Cap:
$53.87B
Revenue:
$303.19B
Net Income/Loss:
$1.40B
P/E Ratio:
39.58
EPS:
7.03
Net Cash Flow:
$-638.10M
1W Performance:
+3.71%
1M Performance:
+9.82%
6M Performance:
+24.17%
1Y Performance:
+14.58%
1-Day Range:
$276.42
$280.00
1-Week Range:
$267.90
$280.69
52-Week Range:
$214.77
$280.69
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
278.28 | 53.87B | 303.19B | 1.40B | -638.10M | 7.03 |
|
MCK
Mckesson Corporation
|
671.82 | 84.34B | 344.58B | 2.83B | 1.63B | 21.84 |
|
CAH
Cardinal Health Inc
|
137.17 | 33.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
69.30 | 8.50B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.25 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Cencora to Announce Q2 Fiscal 2025 Results on May 7 - MSN
Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Jim Cramer on Cencora (COR): “Smart Moves in the Drug Middleman Game!” - Insider Monkey
Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical - Yahoo Finance
$290B Revenue Powerhouse Cencora Sets Critical Q2 Earnings Call Date - Stock Titan
Walden Group sale: DHL & Cencora show interest in deal - Trans.INFO
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
AmerisourceBergen stock soars to all-time high of $271.17 By Investing.com - Investing.com South Africa
Cencora executive chairman sells $3.9 million in stock By Investing.com - Investing.com Canada
Cencora EVP Elizabeth Campbell sells $1.1 million in stock By Investing.com - Investing.com South Africa
Cencora EVP Elizabeth Campbell sells $1.1 million in stock - Investing.com
Cencora executive chairman sells $3.9 million in stock - Investing.com
Deutsche Bank Adjusts Cencora Price Target to $285 From $24 - MarketScreener
AmerisourceBergen stock soars to all-time high of $271.17 - Investing.com
Walgreens Boots Alliance, Inc. Reduces Stake in Cencora Inc. - GuruFocus
Logistics Firm Walden Is Said to Draw Interest from DHL, Cencora - MSN
Insider Sell: Robert Mauch Sells Shares of Cencora Inc (COR) - GuruFocus
Walgreens Boots Alliance, Inc. (NASDAQ:WBA): Business Under Pressure as Legal Risks Mount - Yahoo Finance
Cencora CEO Robert Mauch sells $1.3 million in stock - Investing.com India
Cencora CEO Robert Mauch sells $1.3 million in stock By Investing.com - Investing.com South Africa
Here is Why Growth Investors Should Buy Cencora (COR) Now - Yahoo Finance
Cencora : EEO-1 Disclosure -March 17, 2025 at 09:42 am EDT - Marketscreener.com
Cencora, Inc. (COR): Among Top Insider Sales Last Month - Insider Monkey
What Analysts Are Saying About Cencora Stock - Benzinga
Wells Fargo Adjusts Price Target on Cencora to $274 From $251, Maintains Equalweight Rating - Marketscreener.com
CVS Health (CVS) Down 0.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Top 10 Insider Sales Last Month - Insider Monkey
SBI Securities Co. Ltd. Makes New Investment in Cencora, Inc. (NYSE:COR) - Defense World
Farminveste Says End Of Offer Period For Bond Loan 2025-2029 Changed To March 17 From March 14 - Marketscreener.com
Insider Sell: Silvana Battaglia Sells 5,000 Shares of Cencora In - GuruFocus.com
Is Cencora Stock Outperforming the Nasdaq? - MSN
Is Cencora Stock Outperforming The Nasdaq? - Barchart
Here's Why Cencora (COR) is a Strong Growth Stock - Yahoo Finance
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Amundi Purchases 314,846 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora (NYSE:COR) Rating Increased to Buy at StockNews.com - Defense World
Cencora’s chief accounting officer sells $520,120 in stock By Investing.com - Investing.com Canada
Cencora’s chief accounting officer sells $520,120 in stock - Investing.com
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Cencora, Inc. (COR): Among Stocks With At Least $30 Million In Insider Sales Recently - Insider Monkey
Jones Financial Companies Lllp Has $537,000 Stock Holdings in Cencora, Inc. (NYSE:COR) - Defense World
Cencora, Inc. shareholders approve executive compensation, elect directors - Investing.com
Cencora, Inc. shareholders approve executive compensation, elect directors By Investing.com - Investing.com UK
AmerisourceBergen stock hits all-time high at $262.26 - Investing.com India
AmerisourceBergen stock hits all-time high at $262.26 By Investing.com - Investing.com South Africa
Cencora to Update 2025 Financial Guidance at Conference - TipRanks
CencoraAdjusted EPS For Fiscal 2025 Is Now Expected To Be In Range Of $15.30 To $15.60 - Marketscreener.com
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):